


































Inducing beta-cell replication as a means of increasing 
beta-cell mass is a major goal of diabetes research. 
There has been tremendous controversy about the extent 
to which beta-cells replicate, but it is becoming 
increasingly clear that in adult animals and humans, the 
rate of beta-cell turnover, whether by replication or 
neogenesis, is low under most circumstances [1,2,3]. In 
mice, beta-cells have been found to replicate in a small 
number of physiologically relevant settings, including 
during embryogenesis and early in postnatal life, during 
pregnancy, and in response to obesity [4]. In humans, it 
appears that postnatal beta-cell replication is more 
variable than in mice, but there are indications that most 
takes place during infancy [5]. Beta-cell replication 
declines precipitously with age in mice [1,6] and in 
humans, where age-related loss of replicative ability and 
expression of important beta-cell transcription factors 
occurs [7]. Recently, examination of the rate of 
lipofuscin in human  beta-cells  revealed that  there  was  
 
 































little to no beta-cell turnover in adult humans [2]. A 
similar finding, also in humans came from examination 
by radiocarbon dating and BrdU incorporation [3].  
 
While beta-cell replication appears to decline with age, 
that does not mean that it cannot occur with an 
appropriate stimulus. In vivo, growth factors such as 
exendin-4, EGF, and gastrin have been studied as 
potential inducers of beta-cell replication [8]. In vitro, 
Hayek and coworkers reported that human beta-cells 
can be stimulated to enter the cell cycle in vitro when 
cultured on a complex extracellular matrix [9], but this 
has been disputed as possibly being due to replication 
of exocrine cells contaminating the islet preparations 
[10]. Recently, it was reported that overexpression of 
cdk6, an important cell cycle regulatory protein, 
induced human beta-cells to enter the cell cycle [11]. 
However, there was no evidence of actual proliferation 
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of inducing beta-cells to replicate in vivo or in vitro, 
studying beta-cell replication must rely on the 
examination of the expression of proteins that are 
important in that process [12]. Centromere Protein A 
(CENP-A) is a 17 kDa member of the histone family. 
It is over 60% identical in amino acid sequence to 
histone H3 at the C-terminus, but is highly variable at 
the N-terminus. It is found in the nucleosomes of 












































histone H3. Its presence is required for centromere 
function, with absence leading to chromosome mis-
segregation and cell death [13]. It may also play a role 
in repair of double stranded DNA breaks [14]. CENP-
A expression is regulated throughout the cell cycle at 
both the transcriptional and post-transcriptional levels 
[15]. However, it is thought to be expressed 
ubiquitously. To date, there are no studies that have 












































Representative  low  power  (a‐c)  and  corresponding  high  power  (d‐f)  images  from  human  pancreases  and  islet
preparations immunostained for CENP‐A (green) and insulin (red) in fetal pancreas (a, d, N=7), cultured islets from
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CENP-A protein decreases with age in human islets, 
but not exocrine cells 
 
In the human pancreas, CENP-A protein expression 
exhibited an inverse relationship with age. In the human 
fetal pancreas, where 7 different pancreases were 
examined, 100% of beta-cells exhibited nuclear staining 
for CENP-A (Figure 1a, d). This staining occurred in a 
punctuate pattern and no difference was observed in the 
pattern of CENP-A between beta-cells and other cells in 
the pancreas. CENP-A expression in beta-cells declined 
rapidly with age and by age 30 was undetectable (Figure 
1b, c, e, f, quantitated in g). Alpha-cells also lost CENP-
A with age (Figure 1h, i). In contrast to beta-cells, 
exocrine cells continued to express CENP-A at 
approximately the same level from ages 18-45 (Figure 




































The decline in CENP-A protein in islets is less 
dramatic in mouse islets than in human islets 
 
In the mouse, CENP-A protein expression also declined 
with age (Figure 2a-f, quantitated in g). However, 
unlike the human pancreas, it continued to be detectable 
in the majority of beta-cells even at 16 months, the last 
time point examined. While CENP-A continued to be 
expressed in most beta-cells, the number of CENP-A 
foci in the nucleus declined with age (Figure 2d, e, f, 
quantitated in g). In contrast with the human pancreas, 
mouse CENP-A was upregulated in dividing cells 
compared with non-dividing cells (Figure 2h-m). In the 
human fetal pancreas, the only place where a substantial 
number of dividing cells could be detected in the 
pancreas, there were no cells expressing high levels of 
CENP-A, despite the presence of dividing cells 
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To determine whether the decline in CENP-A 
expression was transcriptional or post-transcriptional, 
we measured CENP-A mRNA levels by quantitative 
RT-PCR in preparations of cultured human islets. There 
was no correlation between CENP-A expression and 
age (Figure 3a, R
2=0.017). In addition, there was no 
correlation  between the level of CENP-A mRNA and 
islet purity, which is consistent with the absence of age-
related effects on CENP-A mRNA expression, given 
that we found no change in CENP-A expression in the 
exocrine pancreas with increasing age (Figure 3b, 
R
2=0.016). Thus, the decline in CENP-A expression in 








































While it is clear that beta-cell replication declines with 
age in humans and mice, the responsible mechanism(s) 
remain to be elucidated. Prior to this report, the only 
cell cycle regulatory protein that had been shown to 
exhibit age-related change was the cyclin dependent 
kinase inhibitor p16INK4A, which increases in beta-
cells with age in vivo [16,17], and in human beta-cells 
stimulated to divide in vitro [18]. Recently, it was 
shown that Ezh2, a histone methyltransferase that is part 
of a Polycomb transcriptional repressor complex, 
represses p16INK4A in beta-cells and declines with age 
in both mice and humans, leading to an increase in 
p16INK4A expression [16]. Interestingly, the kinetics 
of decline described for Ezh2 appear similar to what we 
found for CENP-A, with both exhibiting substantial loss 
by early adulthood. Also of note, the increase in 
p16INK4A and decrease in CENP-A is beta-cell 
specific, as in neither case is there a change with age in 
the exocrine pancreas [17] (Figure 1). 
 
CENP-A has not been recognized to be a senescence 
marker and so its loss in beta-cells over time might 
reflect a phenomenon other than simple cellular 
senescence. CENP-A is regulated by FoxM1 [19] and 
its mRNA increases following partial pancreatectomy 
[20]. The ability of CENP-A to access centromeric 
chromatin is regulated by histone acetylation, and 
treatment with the histone deacetylase inhibitor 
trichostatin A allowed CENP-A to bind to centromeres 
in cells lacking lacking the centromere protein hMis18α 
[21]. Treatment of human islets with trichostatin A did 
not result in increased CENP-A expression 
(unpublished results). However, we find here that the 
decline in CENP-A is due to post-transcriptional 
regulation, which has not been previously reported.  
 
Because CENP-A is required for cell division, the 
finding that it declines with age suggests the possibility 
that increased p16INK4A is not solely responsible for 
the decline in beta-cell replication with age, particularly 
in humans. It cannot be determined whether CENP-A is 
completely absent from beta-cells or whether its 
expression has decreased below the limit of detection of 
immunostaining. Decreasing CENP-A by RNAi, which 
reduces but does not eliminate gene expression, led to a 
profound defect in cell division , suggesting that even 
partial loss of CENP-A could be significant [22].  
 
Clearly, the possibility exists that more defects in aged 
beta-cells remain to be uncovered. The finding reported 
here does not rule out a model in which there is a 
common upstream regulator of CENP-A, p16INK4A, 
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a 
b related replicative decline, but the fact that p16INK4A 
is transcriptionally regulated while the decline in 
CENP-A appears to be post-transcriptional suggests that 
multiple mechanisms may be operative. The possibility 
that multiple events are involved in distinct proliferative 
defects could greatly complicate efforts to enhance beta-




Cells and Tissues. Human fetal pancreases at 18-21 
gestational weeks and cold ischemia time within 12-24 
hours were obtained from Advanced Bioscience 
Resource, Oakland, CA. Tissue procurement was done 
in accordance with Institutional IRB regulations. 
Murine pancreases were harvested from FVB mice 
purchased from Harlan Sprague Dawley. Principles of 
laboratory animal care’ (NIH publication no. 85–23, 
revised 1985; http://grants1.nih.gov/grants/olaw/referen- 
ces/phspol.htm) were followed. 
 
Primary adult human islets and exocrine tissues were 
obtained from the NIH Islet Cell Resources-
Administrative and Bioinformatics Coordinating Center 
(ICR-ABCC), JDRF, and University of Alberta Islet 
Isolation Center, Canada. Primary cells were cultured in 
5.5mM glucose RPMI /10% FBS/1% Pen/Strep 
(Invitrogen) on HTB9 matrix plates or collagen plates 
(Becton Dickinson) in 5% CO2 incubator for 2-3 days 
to form monolayers prior to fixation and analysis [23]. 
 
Immunohistochemistry. Human fetal pancreas and mice 
tissues were fixed in cold methanol and embedded in 
OCT freezing media. Samples were sectioned to a mean 
thickness of 5 microns. Cultured cells and tissues were 
fixed with cold methanol for 10min, blocked for 1hr, 
and incubated with primary antibody for 16hr at 4°C. 
  
Antibodies used were as follows: anti-CENP-A (Abcam 
ab13939, Cell Signaling 2048S), anti-insulin (Santa 
Cruz sc-9168, sc-8033), anti-glucagon (Sigma G2654, 
Abcam ab8055), anti-PanCK (Dako Z0622) and anti-
Ki67 (Dako M7249, M7240). For fluorescent imaging, 
samples were incubated with Alexa 488 (Invitrogen), 
Rhodamine (Jackson) fluor-labeled anti-
mouse/rabbit/rat and nuclear counterstained with DAPI 
(Sigma).  
 
The antibody to human CENP-A has been used 
extensively in the past [24,25]. It was further 
characterized by us by transfection (Lipofectamine 
2000, Invitrogen) into mouse 4T1 cells of an expression 
vector encoding a human CENP-A-GFP fusion gene 
[14]. GFP-expressing cells stained only with human 
CENP-A antibody and there was no staining in 
untransfected mouse cells (Supp. Figure). 
 
For quantitative analysis, cells were scored as positive 
for CENP-A if any immunofluorescence signal was 
detected in nucleus. More than 1000 PanCK and 100 
insulin positive cells were counted from each human 
donor. More than 20 islets were analyzed in the mouse 
pancreas for each animal.  
 
Quantitative RT-PCR. Total RNA extracted from 
human islets and exocrine cells with RNeasy Mini kit 
(Qiagen). 1ug of total RNA prepared for cDNA and 2ul 
of cDNA used as template. Human CENP-A PCR 
conditions were 5 min at 94 °C, followed by 28 cycles 
of 94 °C for 45 sec, 60 °C for 45 sec, and 72 °C for 45 
sec. Quantitative RT-PCR used the Opticon Real-Time 
System (BioRad), with SYBR Green (BioPioneer). RT-
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Supplemental  Figure. Specificity  of  human  CENP‐A 
antibody.  A  plasmid  expressing  a  human  CENP‐A‐GFP  fusion 
protein  [14]  was  transfected  into  4T1  mouse  cells  with 
Lipofectamine and immunostained for human CENP‐A antibody 
(a‐c,  green‐GFP,  red‐human  CENP‐A,  yellow‐merge).  Human 
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